Cite
HARVARD Citation
Fleischmann, R. et al. (n.d.). THU0153 Improvements in disease activity score by baseline status: Pooled analysis of five phase 3 studies with tofacitinib (CP-690, 550) in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. p. 207. [Online].